Alpha 2.0
Login Register
» Authors » Emirena Garrafa

Emirena Garrafa

Explore the profile of Emirena Garrafa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 1265
Followers 0
Related Specialties
Allergy & Immunology
Biochemistry
Biology
Top 10 Co-Authors
Franco Franceschini
Arnaldo Caruso
Silvia Piantoni
Ilaria Cavazzana
Marika Vezzoli
Simona Fiorentini
Anna Bagnato
Laura Andreoli
Francesca Spinella
Laura Rosano
Published In
Bioanalysis
Diagnostics (Basel)
Clin Exp Rheumatol
Proc Natl Acad Sci U S A
Cancer Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Evolution of autoimmune diagnostics over the past 10 years: lessons learned from the UK NEQAS external quality assessment EQA programs
Garrafa E, Carbone T, Infantino M, Anzivino P, Boni M, Ghisellini S, et al.
Clin Chem Lab Med . 2025 Jan; PMID: 39781619
Objectives: External quality assessment (EQA) programs play a pivotal role in harmonizing laboratory practices, offering users a benchmark system to evaluate their own performance and identify areas requiring improvement. The...
2.
Seasonal patterns of myositis-specific and myositis-associated autoantibodies in Italy: Seasonal patterns of myositis autoantibodies
Palterer B, Mazzoni A, Infantino M, Semeraro R, Manfredi M, Pesce G, et al.
Immunol Lett . 2024 Dec; 272:106966. PMID: 39681209
Objective: Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of systemic autoimmune disorders affecting skeletal muscles but also other organs. There are different forms of IIM, each with peculiar clinical...
3.
Harmonization of anti-nuclear antibody testing (ANA) by indirect immunofluorescence assay: Results from ten years of UK NEQAS external quality assessment
Infantino M, Carbone T, Patel D, Sargur R, Stanley C, Bhayat-Cammack A, et al.
Clin Chim Acta . 2024 Dec; 567():120088. PMID: 39667423
External quality assurance (EQA) programs play a pivotal role in monitoring laboratory practices, allowing each laboratory to evaluate the consistency of results across different methods as well the ability of...
4.
Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses
Angeli F, Pedretti E, Garrafa E, Fredi M, Ceribelli A, Franceschini F, et al.
Diagnostics (Basel) . 2024 Oct; 14(19). PMID: 39410596
the reference method for detection of myositis-specific and myositis-associated antibodies (MSAs and MAAs) is considered immunoprecipitation (IP), but it is routinely replaced by semi-automated methods, like lineblot (LB). Few data...
5.
A Mediterranean Diet-Oriented Intervention Rescues Impaired Blood Cell Bioenergetics in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Segala A, Vezzoli M, Vetturi A, Garrafa E, Zanini B, Bottani E, et al.
Diagnostics (Basel) . 2024 Sep; 14(18). PMID: 39335721
: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), a novel term for Non-Alcoholic Fatty Liver Disease (NAFLD), is associated with liver mitochondrial dysfunction. We previously demonstrated that mitochondrial respiratory capacity in...
6.
Sustained post-rituximab B-cell depletion is common in ANCA-associated vasculitis and is affected by sex and renal function
Mescia F, Salviani C, Tonoli M, Affatato S, Moratto D, Tedesco M, et al.
Nephrol Dial Transplant . 2023 Sep; 39(4):683-693. PMID: 37673675
Objective: Despite the increasing use of rituximab in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), it remains unclear what the optimal dosing is, especially for maintenance of remission. A deeper understanding...
7.
Human iPSC-Derived 3D Hepatic Organoids in a Miniaturized Dynamic Culture System
Calamaio S, Serzanti M, Boniotti J, Fra A, Garrafa E, Cominelli M, et al.
Biomedicines . 2023 Aug; 11(8). PMID: 37626611
The process of identifying and approving a new drug is a time-consuming and expensive procedure. One of the biggest issues to overcome is the risk of hepatotoxicity, which is one...
8.
Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment
Caproli A, Pina S, Vezzoli M, Cavazzana I, Airo P, Brugnoni D, et al.
Bioanalysis . 2023 Aug; 15(18):1111-1113. PMID: 37584369
No abstract available.
9.
Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells as Novel Diagnostic Tools for Non-Alcoholic Fatty Liver Disease: Visualizing Relationships with Known and Potential Disease Biomarkers
Garrafa E, Segala A, Vezzoli M, Bottani E, Zanini B, Vetturi A, et al.
Diagnostics (Basel) . 2023 Jul; 13(14). PMID: 37510108
Non-alcoholic fatty liver disease (NAFLD) is a health emergency worldwide due to its high prevalence and the lack of specific therapies. Noninvasive biomarkers supporting NAFLD diagnosis are urgently needed. Liver...
10.
Longitudinal Characterization of Immune Response in a Cohort of Children Hospitalized with Multisystem Inflammatory Syndrome
Dotta L, Moratto D, Cattalini M, Brambilla S, Giustini V, Meini A, et al.
Children (Basel) . 2023 Jun; 10(6). PMID: 37371300
Background: Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe complication of SARS-CoV-2 infection caused by hyperactivation of the immune system. Methods: this is a retrospective analysis of clinical data,...